| ¿µ¹® | lipid | ÇÑ±Û | ÁöÁú |
|---|---|---|---|
| ¼³¸í | »ý¹°Ã¼ ¾È¿¡ Á¸ÀçÇÏ¸ç ¹°¿¡ ³ìÁö ¾Æ´ÏÇϰí, À¯±â¿ë¸Å¿¡ ³ì´Â À¯±âÈÇÕ¹°À» ÅëÆ²¾î À̸£´Â ¸». Á¼Àº Àǹ̷δ ¹°¿¡ ³ìÁö ¾Ê°í ¾ËÄÚ¿Ã, ÄÝ·Î·ÎÆ÷¸§À̳ª ¿¡Å׸£, º¥Á¨ µîÀÇ ºñ±Ø¼º¿ë¸Å¿¡ ³ì´Â Áö¹æ»êÀÇ ¿¡½ºÅ׸£·Î »ýü¿¡ ÀÌ¿ëµÇ´Â À¯±âÈÇÕ¹°ÀÌ´Ù. ´Ü¼øÁöÁú, º¹ÇÕÁöÁú(ÀÎÁöÁú, ´çÁöÁú, Áö´Ü¹é) ¹× À¯µµÁöÁú(ÁöÁúÀÇ °¡¼öºÐÇØ»ê¹°)·Î ºÐ·ùµÈ´Ù. ƯÈ÷ Áß¼ºÁö¹æÀº Áö¹æ»ê°ú ±Û¸®¼¼¸°°úÀÇ ¿¡½ºÅ׸£·Î ´Ü¹éÁú°ú ´ç°ú ÇÔ²² »ýüÀÇ Áֿ伺ºÐ ¹× ¿¡³ÊÁö¿øÀ¸·Î¼ Áß¿äÇÏ´Ù. ±¤ÀǷδ ½ºÅ×·ÎÀÌµå µîÀ» Æ÷ÇÔÇØ¼ È£¸£¸ó, ºñŸ¹Î ·ù·Î¼ ÀÛ¿ëÇÏ´Â °Í µîÀ¸·Î ´Ù¾çÇÑ »ý¸®ÇÐÀû ±â´ÉÀ» ´ã´çÇϰí ÀÖ´Ù. |
||
| ¿µ¹® | pneumonia | ÇÑ±Û | Æó·Å |
|---|---|---|---|
| ¼³¸í | ÆóÀÇ ¿°ÁõÀ¸·Î ÆóÆ÷ ³»¿¡ °ø±â ´ë½Å ¿°Áõ ¼¼Æ÷³ª »ïÃâ¾×À¸·Î °¡µæ Â÷ È£Èí°ï¶õÀ» ¾ß±âÇϸç, ¹ß¿ µîÀÇ Àü½Å Áõ»óÀ» µ¿¹ÝÇÑ´Ù. À§Ä¡, ¿øÀÎ±Õ µî¿¡ µû¶ó ±¸ºÐÇÑ´Ù. ¿¹¸¦ µé¾î, ´ë¿±¼º Æó·Å(lobar pneumonia)¶õ Æó·Å ±¸±Õ¿¡ ÀÇÇÑ ±Þ¼º Æä·ÅÀ¸·Î ÇÑ °³ ¶Ç´Â ¿©·¯ °³ÀÇ Æó¿±À» µû¶ó »ý±â´Â ±¤¹üÀ§ÇÑ »ïÃ⼺ °æÈ°¡ Ư¡ÀÎ º´À» ÁöĪÇÑ´Ù. À̰ÍÀº Æó·ÅÀÇ ¹ß»ýºÎÀ§¿¡ µû¶ó ºÎ¸£´Â ¸»ÀÌ´Ù. ±×¸®°í ¹ÙÀÌ·¯½ºÆó·Å(viral pneumonia)¶õ ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ ¹ß»ýÇÏ´Â ¸ðµç Æó·ÅÀ» ¸»Çϴµ¥, À̰ÍÀº ¿øÀαտ¡ µû¶ó ÁöĪÇÑ ¸»ÀÌ´Ù. |
||
| ¿µ¹® | aspiration pneumonia | ÇÑ±Û | ÈíÀÎÆó·Å |
|---|---|---|---|
| ¼³¸í | À½½Ä¹°ÀÇ Â±â°°Àº À̹°ÀÌ ±âµµ¿¡ µé¾î°¡ ÀÌÂ÷ÀûÀ¸·Î »ý±â´Â Æó·Å. À½½Ä¹°À̳ª ÀÔ¾ÈÀÇ ¹Ì»ý¹°ÀÌ ½Äµµ·Î ³Ñ¾î°¡Áö ¾Ê°í ±âµµ·Î À߸ø ÈíÀÎµÇ¾î ¾ß±âµÇ´Â Æó·ÅÀ» ¸»ÇÑ´Ù. ÈíÀÎ ¹°ÁúÀÇ Æ¯¼º¿¡ µû¶ó¼ ¼¼ °¡Áö ÁõÈıºÀ» Æ÷ÇÔÇÑ´Ù. ¨ç ÈÇÐÀû Æó·ÅÀº Á÷Á¢ÀûÀ¸·Î Æó¿¡ À¯ÇØÇÑ ¹°ÁúÀ» ÈíÀÎÇßÀ» ¶§ ÀϾ¸ç, ±Þ¼º È£Èí°ï¶õ, ºü¸¥ È£Èí, ºü¸¥¸ÆÀÌ ³ªÅ¸³ª°í µ¿¹ÝµÇ´Â Áõ»óÀº ÁַΠû»öÁõ, ±â°üÁö °æ·Ã, ¿ µîÀÌ´Ù. ¨è Çϱ⵵ÀÇ ¼¼±Õ¼º °¨¿°ÀÌ ÈíÀμº Æó·ÅÀÇ °¡Àå ÈçÇÑ ÇüÅ·Î, ±âħ, ¹ß¿, °í¸§°¡·¡ Áõ»óÀ» ³ªÅ¸³½´Ù. ¨é Çϱ⵵ÀÇ ±â°èÀû Æó¼â´Â Ưº°ÇÑ ¹°Áú, ƯÈ÷ ¶¥Äá, ÀÛÀº °í±âµ¢¾î¸®¿¡ ÀÇÇØ ÈíÀεǾúÀ» ¶§ ÀϾ¸ç, ÈíÀÎ ¹°Áú°ú ±âµµÀÇ Á÷°æ¿¡ µû¶ó Áõ»óÀº ´Ù¸£´Ù. ±â°ü¿¡¼ ¸·È÷¸é Á¾Á¾ È£Èí°ï¶õ°ú ÇÔ²² »ç¸Á¿¡ À̸£±âµµ Çϸç, Çϱ⵵ ¾Æ·¡ ºÎºÐ¿¡¼ ÈíÀÎÀÌ ÀϾ¸é ¸¸¼º ±âħÀÌ ¹ß»ýÇÑ´Ù. |
||
| AP | accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p... |
|---|---|
| ALLHAT | Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial |
| ANRL | antihypertensive neutral renomedullary lipid |
| BLM | bilayer lipid membrane; bimolecular liquid membrane; bleomycin; buccolinguomasticatory |
| CLL | cholesterol-lowering lipid; chronic lymphatic leukemia; chronic lymphocytic leukemia; cow lung lavag... |
| AEP | Acute eosinophilic pneumonia |
|---|---|
| BOOP | Bronchiolitis Obliterans Organising Pneumonia |
| BOOP | Bronchiolitis obliterans with organizing pneumonia |
| CEP | Chronic eosinophilic pneumonia |
| CAP | Community Acquired Pneumonia |
| lipid pneumonia | Lipoid pneumonia, pulmonary condition marked by inflammatory and fibrotic changes in the lungs due to the inhalation of various oily or fatty substances, particularly liquid petrolatum, or resulting from accumulation in the lungs of endogenous lipid material, either cholesterol from obstructive pneumonitis or following fracture of a bone; phagocytes containing lipid are usually present. Synonym: oil pneumonia. (05 Mar 2000) |
|---|
| pneumonia, lipid | Pneumonia due to aspiration or inhalation of various oily or fatty substances. (12 Dec 1998) |
|---|---|
| anisotropic lipid | A lipid in the form of doubly refractive droplets. (05 Mar 2000) |
| annular lipid | The layer(s) of lipid bound to and/or surrounding an integral membrane protein. (05 Mar 2000) |
| brain lipid | Impure cephalin possessing marked haemostatic action when locally applied. (05 Mar 2000) |
| galactose-diphosphoglycosyl carrier lipid synthetase | <enzyme> Catalyses synthesis of gcl-pp-gal from udp gal and p-gcl; also catalyses exchange between the uridylyl moiety of udpgal and ump Registry number: EC 2.4.1.- (26 Jun 1999) |
| neutral lipid storage disease | <syndrome> Congenital ichthyosis, leukocyte vacuoles, and variable involvement of other organ systems. Synonym: neutral lipid storage disease. (05 Mar 2000) |
| disease, lipid storage | A series of disorders due to inborn errors in lipid metabolism resulting in the abnormal accumulation of lipids in the wrong places (Examples include Gaucher, Fabry and Niemann-Pick diseases and metachromatic leukodystrophy). (12 Dec 1998) |
| inositol lipid | A membrane-anchored phospholipid that transduces hormonal signals by stimulating the release of any of several chemical messengers. (09 Oct 1997) |
| isotropic lipid | A lipid occurring in the form of singly refractive droplets. (05 Mar 2000) |
| lipid | <chemical> Any of a heterogeneous group of flats and fatlike substances characterised by being water insoluble and being extractable by nonpolar (or fat) solvents such as alcohol, ether, chloroform, benzene, etc. All contain as a major constituent aliphatic hydrocarbons. The lipids, which are easily stored in the body, serve as a source of fuel, are an important constituent of cell structure and serve other biological functions. Lipids may be considered to include fatty acids, neutral fats, waxes and steroids. Compound lipids comprise the glycolipids, lipoproteins and phospholipids. (18 Nov 1997) |
| lipid A | The lipid associated with polysaccharide in the lipopolysaccharide of gram-negative bacterial cell walls. (18 Nov 1997) |
| lipid A 4'-phosphatase | <enzyme> Involved in lipid a biosynthesis in rhizobium leguminosarum Registry number: EC 3.1.3.- Synonym: 2-keto-3-deoxyoctulosonate-activated 4'-phosphatase, kdo-activated lipid a 4'-phosphatase (26 Jun 1999) |
| lipid A disaccharide synthase | <enzyme> Udp-diacyl-n-acetylglucosamine plus 2,3-diacyl-n-acetylglucosamine-1-phosphate yields 2',3'-diacyl-glcn-(beta 1-6)-2,3-diacyl-glcn-1-p plus udp Registry number: EC 2.4.1.182 Synonym: 2,3-diacyl-n-acetylglucosamine diacyl-n-acetylglucosaminyltransferse, lipid a synthase (26 Jun 1999) |
| lipid bilayer | <biochemistry> A lamellar organisation of phospholipids that are packed as a bilayer with hydrophobic acyl tails inwardly directed and polar head groups on the outside surfaces. It is this bilayer that forms the basis of membranes in cells, though in most cellular membranes a very substantial proportion of the area may be occupied by integral proteins. The triple layered appearance of membranes seen in electron microscopy is thought to arise because the osmium tetroxide binds to the polar regions leaving a central, unstained, hydrophobic region. (31 Dec 1997) |
| lipid bilayers | Layers of lipid molecules which are two molecules thick. Bilayer systems are frequently studied as models of biological membranes. (12 Dec 1998) |
| lipid pneumonia |
a condition marked by inflammatory and fibrotic changes in the lungs due to the inhalation of oil
Ãâó: depts.washington.edu/pwdlearn/web/glossary/glossar...
|
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|